Compare NSLR & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSLR | SRZN |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.4M | 271.6M |
| IPO Year | 2011 | 2020 |
| Metric | NSLR | SRZN |
|---|---|---|
| Price | $10.39 | $23.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | ★ 281.5K | 277.0K |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 211.25 | N/A |
| EPS | ★ 4.58 | N/A |
| Revenue | N/A | ★ $3,477,000.00 |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.28 | $10.11 |
| 52 Week High | $12.19 | $35.00 |
| Indicator | NSLR | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 54.65 |
| Support Level | $10.13 | $20.26 |
| Resistance Level | $11.24 | $27.37 |
| Average True Range (ATR) | 0.56 | 1.96 |
| MACD | 0.07 | 0.33 |
| Stochastic Oscillator | 56.28 | 62.28 |
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).